Filing details
;

Document Details

Form: 8-K

Filing Date: Apr 29 2021

Document Date: Apr 28 2021

Form Description: Report of unscheduled material events or corporate event

Filing Group: Current Reports

Issuer: AMARIN CORP PLC\UK

Filer:

Document Formats

View HTML

View PDF

View RTF

View XLS

Investor Contact
For corporate governance, analyst coverage, stock information, secretarial matters and other investor-related queries, please use the contact form
About Amarin for Investors
Amarin is a leading cardiovascular health pharmaceutical company. As leaders, we apply science, research, passion and global knowledge to ensure we encompass our vision of stopping heart disease from being a leading cause of death. In order to achieve this vision, we take a strategic approach to management and financial responsibility.

Corporate Governance
Gain new insights into Amarin’s performance and corporate commitments.
Financial Information
Learn more about Amarin’s revenue, expenses, profit and loss, as well as a comprehensive overview of the company’s financial health.
Analyst Coverage
Find out which firms and analysts are covering Amarin.
Stock Information
View real-time stock prices and stock quotes.

About Amarin
A new paradigm in cardiovascular health management
Amarin Corporation is focused on a BOLD vision to stop cardiovascular disease from being a leading cause of death. Find out more about our vision and how we lead the way to better care for those with cardiovascular disease.
Science and Health
Passionate about cardiometabolic science and health
Learn more about the science underpinning our product and research & development efforts to advance innovation in cardiovascular disease.
News and Media
Press releases, news, updates and statements
From reports and reviews to partnerships and innovations, find out more about Amarin's latest news and stories as they stand in the press.
ALL-NP-00016 1/23